The Na-H exchanger revisited: An update on Na-H exchange regulation and the role of the exchanger in hypertension and cardiac function in health and disease

Cardiovascular Research

Volumn 36, Issue 2, 1997, Pages 138-148

  Fröhlich, Otto ^a   Karmazyn, Morris ^b  

^a EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF WESTERN ONTARIO   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

(3 METHYLSULFONYL 4 PIPERIDINOBENZOYL)GUANIDINE METHANESULFONATE; AMILORIDE; CARDIOVASCULAR AGENT; CARIPORIDE; UNCLASSIFIED DRUG;

HEART FUNCTION; HEART INFARCTION; HEART INFARCTION PREVENTION; HEART MUSCLE ISCHEMIA; HEART PROTECTION; HUMAN; HYPERTENSION; NONHUMAN; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROTON SODIUM EXCHANGE; REVIEW; SIGNAL TRANSDUCTION; TRANSCRIPTION REGULATION;

ANTI-ARRHYTHMIA AGENTS; CARDIOVASCULAR DISEASES; HUMANS; HYPERTENSION; ISOMERISM; MYOCARDIAL CONTRACTION; MYOCARDIUM; SECOND MESSENGER SYSTEMS; SODIUM-HYDROGEN ANTIPORTER;

EID: 0031281724     PISSN: 00086363     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0008-6363(97)00200-9     Document Type: Review

References (115)

1. Avkiran M. Sodium-hydrogen exchange in myocardial ischemia and reperfusion: A critical determinant of injury? In: Karmazyn M, editor. Myocardial Ischemia: Mechanisms, Reperfusion, Protection. Basel: Birkhäuser, 1996:299-311.
2. + Exchanger. Austin: R.G. Landes Company, 1996:189-215.
3. Karmazyn M. The sodium-hydrogen exchange system in the heart. Its role in ischemic and reperfusion injury and thereapeutic implications. Can J Cardiol. 12:1996;1074-1082.
4. + exchangers. Physiol Rev. 77:1997;51-74.
5. + Exchanger. Austin: R.G. Landes Company, 1996.
6. + exchanger (NHE5/SLC9A5) to chromosome 16q22.1. Genomics. 25:1995;615-622.
7. Szpirer C., Szpirer J., Riviere M., Levan G., Orlowski J. Chromosomal assignment of four genes encoding Na/H exchanger isoforms in human and rat. Mammalian Genome. 5:1994;153-159.
8. + exchanger gene family: structure and function studies. Am J Physiol. 269:1995;G1-11.
9. Fliegel L., Dyck J.R. Molecular biology of the cardiac sodium/hydrogen exchanger. Cardiovasc Res. 29:1995;155-159.
10. Counillon L., Pouysségur J. Structure-function studies and molecular regulation of the growth factor activatable sodium-hydrogen exchanger (NHE-1). Cardiovasc Res. 29:1995;147-154.
11. + exchanger: an update on structure, regulation and cardiac physiology. Biochem J. 296:1993;273-285.
12. + exchanger isoforms (NHE-1, -2, and -3) are differentially responsive to second messenger agonists of the protein kinase A and C pathways. J Biol Chem. 270:1995;29209-29216.
13. + exchanger isoforms NHE2 and NHE3: an effect opposite to that on NHE1. Am J Physiol. 270:1996;G431-441.
14. + exchanger isoform NHE1: role of phosphorylation. Kidney Int. 49:1996;1038-1041.
15. + exchanger (NHE1 isoform) in response to growth factors. J Biol Chem. 272:1997;271-279.
16. + antiporter cytoplasmic domain mediates growth factor signals and controls 'H' sensing. Proc Natl Acad Sci USA. 89:1992;2424-2428.
17. 2+ regulation-defective. J Biol Chem. 269:1994;13710-13715.
18. + antiporter in salivary acinar cells. J Biol Chem. 272:1997;287-294.
19. + exchanger isoform 1 (NHE1) is a novel member of the calmodulin-binding proteins. Identification and characterization of calmodulin-binding sites. J Biol Chem. 269:1994;13703-13709.
20. + antiport. Circ Res. 64:1988;676-685.
21. + exchange in the sheep cardiac Purkinje fibre. J Physiol Lond. 471:1994;583-597.
22. + antiporter. Analysis of phosphorylation and subcellular localization. J Biol Chem. 269:1994;8741-8748.
23. + exchanger. Am J Physiol. 270:1996;C1493-1502.
24. + exchanger interacts with mammalian heat shock protein. Biochemistry. 34:1995;10412-10420.
25. 12 class of G proteins. J Biol Chem. 269:1994;11802-11806.
26. 13 regulate NHE-1 and intracellular calcium in epithelial cells. Am J Physiol. 268:1995;C101-110.
27. 13 stimulates Na-H exchange. J Biol Chem. 269:1994;4721-4724.
28. + exchange through distinct cdc41-dependent and RhoA-dependent pathways. J Biol Chem. 271:1996;6152-6158.
29. + exchange by platelet-derived growth factor involves phosphatidylinositol 3′-kinase and phospholipase Cγ J Biol Chem. 269:1994;30734-30739.
30. + exchanger isoforms. J Biol Chem. 271:1996;22604-22610.
31. + exchange is necessary for RhoA-induced stress fiber formation. J Biol Chem. 271:1996;22281-22284.
32. + exchange in primary rat astrocytes: role of myosin light-chain kinase. Am J Physiol. 269:1995;C257-266.
33. + antiporter NHE1 via mitogen and hypertonic stimulation. J Cell Physiol. 168:1996;8-17.
34. + antiport to osmotic stress. Am J Physiol. 269:1995;C998-1007.
35. + exchanger (NHE-1) gene. Biochim Biophys Acta. 1217:1994;54-64.
36. Kolyada A.Y., Johns C.A., Madias N.E. Role of C/EBP proteins in hepatic and vascular smooth muscle transcription of human NHE1 gene. Am J Physiol. 269:1995;C1408-1416.
37. + exchanger gene by the transcription factor AP-2. J Biol Chem. 270:1995;1375-1381.
38. + exchanger gene during neuronal differentiation of embryonal caarcinoma cells. J Biol Chem. 270:1995;10420-10427.
39. Yang W., Dyck J.R.B., Fliegel L. Regulation of NHE1 expression in L6 muscle cells. Biochem Biophys Acta. 1306:1996;107-113.
40. Yang W., Dyck J.R.B., Wang H., Fliegel L. Regulation of the NHE-1 promoter in mammalian myocardium. Am J Physiol. 270:1996;H259-266.
41. + exchanger gene expression. Role of a novel poly(dA_dT) element in regulation of the NHE1 promoter. J Biol Chem. 271:1996;20444-20449.
42. Siffert W., Düsing R. Sodium-proton exchange and primary hypertension. An update. Hypertension. 26:1995;649-655.
43. Rosskopf D., Frömter E., Siffert W. Hypertensive sodium-proton exchanger phenotype persists in immortalized lymphoblasts from essential hypertensive patients: a cell culture model for human hypertension. J Clin Invest. 92:1993;2553-2559.
44. Rosskopf D., Schröder K., Siffert W. Role of sodium-hydrogen exchange in the proliferation of immortalized lymphoblasts from patients with essential hypertension and normotensive subjects. Cardiovasc Res. 29:1995;254-259.
45. + exchanger expression in vascular smooth muscle of spontaneously hypertensive and Wistar-Kyoto rats. Hypertension. 24:1994;734-738.
46. + antiporter (NHE-1 isoform) in cultured vascular smooth muscle from the spontaneously hypertensive rat. Kidney Int. 47:1995;78-87.
47. Siczkowski M., Davies J.E., Ng L.L. Sodium-hydrogen antiporter protein in normotensive Wistar-Kyoto rats and spontaneously hypertensive rats. J. Hypertens. 12:1994;775-781.
48. + exchange in pulmonary artery smooth muscle from spontaneously hypertensive and Wistar-Kyoto rats. Am J Physiol. 269:1995;L673-680.
49. + exchange in vascular smooth muscle cells from WKY and SHR: effects of phorbol ester. Am J Physiol. 268:1995;C14-20.
50. + exchanger isoform I. Hypertension. 27:1996;859-866.
51. + exchanger isoform I. Metabolism: Clinical and Experimental. 46:1997;250-256.
52. + antiporter phenotype, abundance, and phosphorylation of immortalized lymphoblasts from humans with hypertension. Hypertension. 25:1995;971-977.
53. +-proton exchanger. Circ Res. 76:1995;148-153.
54. + exchanger isoform of renal brush border. Am J Physiol. 265:1993;F736-742.
55. + exchanger isoforms 1 and 3 in kidney proximal tubules of hypertensive rats. Circ Res. 80:1997;853-860.
56. + exchanger overactivity in essential hypertension. Am J Hypertens. 10:1997;84-93.
57. Orchard C.H., Kentish J.C. Effects if changes in pH on the contractile function of cardiac muscle. Am J Physiol. 258:1990;C967-981.
58. Karmazyn M. The role of endothelins in cardiac function in health and disease. In: Karmazyn M, editor. Myocardial Ischemia: Mechanisms, Reperfusion, Protection. Basel: Birkhäuser, 1996:209-230.
59. 1-Adrenergic stimulation of the Na-H exchange in cardiac myocytes. Am J Physiol. 263:1992;C1096-1102.
60. Puçéat M., Vassort G. Neurohumoral modulation of intracellular pH in the heart. Cardiovasc Res. 29:1995;178-183.
61. Matsui H., Barry W.H., Livsey C., Spitzer K.W. Angiotensin II. stimulates sodium-hydrogen exchange in adult rabbit ventricular myocytes. Cardiovasc Res. 29:1995;215-221.
62. Mattiazi A., Perez N.G., Vila-Petrof M.G., Alvarez B., Camillon De Hurtado M.C., Cingolani H.E. Dissociation between positive inotropic and alkalinizing effects of angiotensin II in feline myocardium. Am J Physiol. 272:1997;H1131-1136.
63. + exchanger. Evidence for a receptor-mediated mechanism involving protein kinase C. Circ Res. 79:1996;705-715.
64. + exchange inhibitors in cardiac ischemia. J Mol Cell Cardiol. 24:1992;731-739.
65. + exchange. Basic Res Cardiol. 91:1996;203-209.
66. Koike A., Akita T., Hotta Y., Takeyka K., Kodama I., Murase M., Abe T., Toyama J. Protective effects of dimethyl amiloride against postischemic myocardial dysfunction in rabbit hearts: phosphorus 31-nuclear magnetic resonace measurements of intracellular pH and cellular energy. J Thorac Cardiovasc Surg. 112:1996;765-775.
67. + exchange on intracellular sodium and pH in working and ischemic hearts Magn Res Med. 32:1994;556-564.
68. + exchange attenuates neutrophil-mediated reperfusion injury. Ann Thorac Surg. 60:1995;377-381.
69. + exchange inhibitor in cardiac ischaemia. Br J Pharmacol. 109:1993;562-568.
70. 2+ overload in isolated perfused rabbit heart. Circulation. 89:1994;2787-2798.
71. + exchange inhibition in ischemic, reperfused porcine hearts. Circulation 92:912-917.
72. + exchange inhibitor, on ventricular arrhythmias in animal hearts. Eur J Pharmacol. 317:1996;309-316.
73. + antiporter inhibitor on postischemic reperfusion in pig heart. J Cardiovasc Pharmacol. 23:1994;72-78.
74. + exchange and reperfusion arrhythmias: protection by intracoronary infusion of a novel inhibitor. Am J Physiol. 267:1994;H2430-2440.
75. + exchange inhibitors. Am J Physiol. 270:1996;H692-700.
76. + exchange inhibitor, Hoe 642: Difference from preconditioning in the role of protein kinase C. J Am Coll Cardiol. 29:1997;693-701.
77. Ruiz Petrich E., Ponce Zumino A., Moffat M.P., Rioux Y., Schanne O.F. Modulation of the electrophysiologica effects of ischemia reperfusion by methylisobutyl amiloride. J Mol Cell Cardiol. 28:1996;1129-1141.
78. 2+ in the reperfusate and protective effects of amiloride added to the cardioplegic solution. Heart and Vessels. 10:1995;310-317.
79. Karwatowska-Prokopczuk E., Czarnowska E., Prokopczuk A. Combined therapy with dimethyliourea, diltiazem and amiloride/dimethylamiloride in the ischemic/reperfused heart. Cardiovasc Res. 30:1995;70-78.
80. Mathur S, Karmazyn M. Interaction between anesthetics and the sodium-hydrogen exchange inhibitor 642 (cariporde) in ischemic and reperfused rat hearts. Anesthesiology, 1997, in press.
81. + exchange inhibitor HOE 694. Ann Thorac Surg. 61:1996;1400-1406.
82. 31P NMR study in isolated pig hearts J Mol Cell Cardiol. 27:1995;2237-2248.
83. Askenasy N., Vivi A., Tassini M., Navon G. The relationship between cellular sodium, pH and volumes and the activity of Na/H antiport during hypothermic ischemia: Multinuclear NMR studies of rat hearts. J Mol Cell Cardiol. 28:1996;589-601.
84. Pierce G.N., Czubryt M.P. The contribution of ionic imbalance to ischemia/reperfusion-induced injury. J Mol Cell Cardiol. 27:1995;53-63.
85. + exchange. Am J Physiol. 268:1995;H1531-1539.
86. i. J Surg Res. 59:1995;712-718.
87. + exchange system. Circ Res. 74:1994;794-805.
88. + exchange inhibitors reverse lactate-induced depression in postischaemic ventricular recovery. Br J Pharmacol. 108:1993;50-56.
89. Khandoudi N., Ho J., Karmazyn M. Role of sodium/hydrogen exchange in mediating the effects of endothelin-1 on the normal and ischemic and reperfused heart. Circ Res. 75:1994;369-378.
90. + exchange inhibition protects against mechanical, ultrastructural and biochemical impairment induced by low concentrations of lysophosphatidylcholine in isolated rat hearts. Circ Res. 80:1997;95-102.
91. Hoque A.N.E., Karmazyn M. Effect of sodium-hydrogen exchange inhibition on functional and metabolic impairment produced by oxidative stress in the isolated rat heart. Can J Physiol Pharmacol. 75:1997;326-334.
92. Karmazyn M, Bend JR. Biochemical and molecular mechanisms of myocardial injury. In: Bishop SP, editor. Volume 6, Comprehensive Toxicology (Cardiovascular Toxicology), Amsterdam: Elsevier, 1997, pp. 255-278.
93. Gottlieb R.A., Gruol D.L., Zhu J.Y., Engler R.L. Preconditioning in rabbit cardiomyocytes. Role of pH, vacuolar proton ATPase, and apoptosis. J Clin Invest. 97:1996;2391-2398.
94. Chakrabarti S, Hoque ANE, Karmazyn M. A rapid ischemia-induced apoptosis in isolated rat hearts and its attenuation by the sodium-hydrogen exchange inhibitor HOE 642 (Cariporide). J Mol Cell Cardiol, in press.
95. + exchange blocker amiloride on left ventricular remodeling after anterior myocardial infarction in rats. Cardiovasc Drugs Ther. 9:1995;823-826.
96. + exchange blocker, in a murine model of dilated cardiomyopathy. Res Commun Chem Pathol Pharmacol. 92:1996;201-210.
97. Allard MF, Lopaschuk GD. In: Karmazyn, M, editor. Myocardial Ischemia: Mechanisms, Reperfusion, Protection. Basel: Birkhäuser, 1996:423-441.
98. + buffering capacity in normal and hypertrophied right ventricle of ferret heart. Cardiovasc Res. 31:1996;729-738.
99. + exchange is impaired in cardiac hypertrophy. J Clin Invest. 99:1997;125-135.
100. Steenbergen C., Perlman M.E., London R.E., Murphy E. Mechanisms of precondtioning. Ionic alterations. Circ Res. 72:1993;112-125.
101. Schaefer S., Carr L.J., Prussel E., Ramasamy R. Effects of glycogen depletion on ischemic injury in isolated rat hearts: insights into preconditioning. Am J Physiol. 268:1995;H935-944.
102. de Albuquerque C.P., Gerstenblith G., Weiss R.G. Importance of metabolic inhibition and cellular pH in mediating preconditioning contractile and metabolic effects in rat hearts. Circ Res. 74:1994;139-150.
103. Finegan B.A., Lopaschuk G.D., Ghandi M., Clanachan A.S. Ischemic preconditioning inhibits glycolysis and proton production in isolated working rat hearts. Am J Physiol. 269:1995;H1767-1775.
104. Asimakis G.K., Inners-McBride K., Medellin G., Conti V.R. Ischemic preconditioning attenuates acidosis and postischemic dysfunction in isolated rat heart. Am J Physiol. 263:1992;H887-H894.
105. Ramasamy R., Liu H., Anderson S., Lundmark J., Schaefer S. Ischemic preconditioning stimulates sodium and proton transport in isolated rat hearts. J Clin Invest. 96:1995;1464-1472.
106. Bugge E., Ytrehus K. Inhibition of sodium-hydrogen exchange reduces infarct size in the isolated rat heart - a protective additive to ischaemic preconditioning. Cardiovasc Res. 29:1995;269-274.
107. + exchanger activity does not contribute to protection by ischemic preconditioning in the isolated rat heart. Circulation 1997, in press.
108. Scholz W., Albus U., Counillon L., Gögelein H., Lang H.-J., Linz W., Weichert A., Schölkens B.A. Protective effect of HOE 642, a selective sodium-hydrogen exchange subtype 1 inhibitor, on cardiac ischaemia and reperfusion. Cardiovasc Res. 29:1995;260-268.
109. + exchanger during postnatal development in the rat: changes in mRNA expression and sarcolemmal activity. J Mol Cell Cardiol. 29:1997;321-332.
110. + exchanger (NHE-1) in rabbit. Biochem Biophys Res Commun. 212:1995;960-967.
111. + exchange activity in the spontaneously hypertensive perfused rat heart. J Mol Cell Cardiol. 27:1995;1475-1481.
112. Feuvray D. Response to ischemia and reperfusion by the diabetic heart. In: Karmazyn M, editor. Myocardial Ischemia: Mechanisms, Reperfusion, Protection. Basel: Birkhäuser, 1996:409-421.
113. + exchange in diabetic rat isolated ventricular myocytes. Circ Res. 80:1997;253-260.
114. + current in ventricular myocytes from diabetic rats. Am J Physiol. 271:1996;H2154-2161.
115. Karmazyn M. Sodium-hydrogen exchange inhibition: a superior cardioprotective strategy. J Thorac Cardiovasc Surg. 112:1996;776-777. (editorial).